Lamivudine and Dolutegravir Sodium Tablets

上海迪赛诺医药集团股份有限公司🇨🇳 National Medical Products Administration

Approval Id: 8n5SSWcxYaz
Approval Number: 国药准字H20263881
Generic Name: 拉米夫定多替拉韦片
Generic Name En: Lamivudine and Dolutegravir Sodium Tablets
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含拉米夫定300mg和多替拉韦钠（按C₂₀H₁₉F₂N₃O₅计）50mg
Reg Date: 2026-04-07
Company Name: 上海迪赛诺医药集团股份有限公司
Company Address: 中国（上海）自由贸易试验区张衡路1479号1幢
Production Company Name: 上海迪赛诺医药集团股份有限公司
Production Company Address: 中国（上海）自由贸易试验区张衡路1479号
Company Detail Path: /organization/shang-hai-di-sai-nuo-yi-yao-ji-tuan-gu-fen-you-xian-gong-si
Production Company Detail Path: /organization/shang-hai-di-sai-nuo-yi-yao-ji-tuan-gu-fen-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Apr 7, 2026

Approval ID

8n5SSWcxYaz

Type

化学药品